These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25929909)

  • 21. Myelodysplastic syndrome and acute leukaemia following treatment of soft tissue sarcoma.
    de Graeff A; Vendrik CP; Pinedo HM
    Neth J Med; 1989 Jun; 34(5-6):251-7. PubMed ID: 2671758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of secondary myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in patients with ovarian or breast cancer in a real-world setting in the United States.
    Shenolikar R; Durden E; Meyer N; Lenhart G; Moore K
    Gynecol Oncol; 2018 Nov; 151(2):190-195. PubMed ID: 30268525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-related incidence and other epidemiological aspects of myelodysplastic syndromes.
    Aul C; Gattermann N; Schneider W
    Br J Haematol; 1992 Oct; 82(2):358-67. PubMed ID: 1419819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience.
    Smith RE; Bryant J; DeCillis A; Anderson S;
    J Clin Oncol; 2003 Apr; 21(7):1195-204. PubMed ID: 12663705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcitonin nasal spray and increased cancer risk: a population-based nested case-control study.
    Sun LM; Lin MC; Muo CH; Liang JA; Kao CH
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4259-64. PubMed ID: 25144633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association between non-steroidal anti-inflammatory drugs (NSAIDs) and myelodysplastic syndromes in the Adults in Minnesota with Myelodysplastic Syndromes (AIMMS) Study.
    Hubbard AK; Richardson M; Rosesler MA; Cioc A; Nguyen PL; Warlick E; Poynter JN
    Leuk Lymphoma; 2021 Jun; 62(6):1474-1481. PubMed ID: 33416407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy-related myelodysplastic syndrome following primary breast cancer.
    Malmgren JA; Calip GS; Pyott SM; Atwood MK; Kaplan HG
    Leuk Res; 2016 Aug; 47():178-84. PubMed ID: 27414978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapy-related acute myeloid leukaemia and myelodysplastic syndrome in Victoria, Australia 2003-2014.
    Ong DM; Farrugia H; Wei A
    Intern Med J; 2018 Jul; 48(7):822-829. PubMed ID: 29236346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of acute myelogenous leukaemia and myelodysplasia following cancer treatment.
    van Leeuwen FE
    Baillieres Clin Haematol; 1996 Mar; 9(1):57-85. PubMed ID: 8730551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis of secondary myelodysplastic syndromes (MDS) following autologous transplantation should not be based only on morphological criteria used for diagnosis of de novo MDS.
    Amigo ML; del Cañizo MC; Rios A; Garcia MA; Caballero MD; Martin A; Bermejo N; Vilches P; San Miguel JF
    Bone Marrow Transplant; 1999 May; 23(10):997-1002. PubMed ID: 10373064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concomitant chemo-radiotherapy and local dose of radiation as risk factors for second malignant neoplasms after solid cancer in childhood: a case-control study.
    Guérin S; Guibout C; Shamsaldin A; Dondon MG; Diallo I; Hawkins M; Oberlin O; Hartmann O; Michon J; Le Deley MC; de Vathaire F
    Int J Cancer; 2007 Jan; 120(1):96-102. PubMed ID: 17013899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies.
    Kollmannsberger C; Hartmann JT; Kanz L; Bokemeyer C
    J Cancer Res Clin Oncol; 1998; 124(3-4):207-14. PubMed ID: 9619748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of myelodysplastic syndromes.
    Strom SS; Vélez-Bravo V; Estey EH
    Semin Hematol; 2008 Jan; 45(1):8-13. PubMed ID: 18179964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The heterogeneity of leukemia occurring after treatment for sarcoma.
    Varterasian M; Zalupski M; Karanes C
    Am J Clin Oncol; 1997 Dec; 20(6):585-6. PubMed ID: 9391546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tea consumption reduces the risk of de novo myelodysplastic syndromes.
    Liu P; Zhang M; Jin J; Holman CD
    Leuk Res; 2015 Feb; 39(2):164-9. PubMed ID: 25529769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000-2014.
    Teepen JC; Curtis RE; Dores GM; Berrington de Gonzalez A; van den Heuvel-Eibrink MM; Kremer LCM; Gilbert ES; van Leeuwen FE; Ronckers CM; Morton LM
    Leukemia; 2018 Dec; 32(12):2580-2589. PubMed ID: 29795414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood.
    Le Vu B; de Vathaire F; Shamsaldin A; Hawkins MM; Grimaud E; Hardiman C; Diallo I; Vassal G; Bessa E; Campbell S; Panis X; Daly-Schveitzer N; Lagrange JL; Zucker JM; Eschwège F; Chavaudra J; Lemerle J
    Int J Cancer; 1998 Jul; 77(3):370-7. PubMed ID: 9663598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The epidemiology of myelodysplastic syndromes.
    Sekeres MA
    Hematol Oncol Clin North Am; 2010 Apr; 24(2):287-94. PubMed ID: 20359626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risks of Venous Thromboembolism, Stroke, Heart Disease, and Myelodysplastic Syndrome Associated With Hematopoietic Growth Factors in a Large Population-Based Cohort of Patients With Colorectal Cancer.
    Du XL; Zhang Y
    Clin Colorectal Cancer; 2015 Dec; 14(4):e21-31. PubMed ID: 26119923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies.
    Darrington DL; Vose JM; Anderson JR; Bierman PJ; Bishop MR; Chan WC; Morris ME; Reed EC; Sanger WG; Tarantolo SR
    J Clin Oncol; 1994 Dec; 12(12):2527-34. PubMed ID: 7989926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.